Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhixian Yu

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Cancer Research and Clinical Oncology|March 8, 2025
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validationYifei Li, Congcong Fan, Feng Jiang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 16, 2015
[Association of polymorphism in the promoter region of PCA3 gene with risk of prosate cancer]Wu Zhou, Zhihua Tao, Zhongyong Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 13, 2023
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11Zhichao Lang, Suhui Yu, Yuhang Hu, et al.
Chemico-Biological Interactions|July 11, 2026
MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylationWeiping Huang, Feng Jiang, Weizhi Zhang, et al.
Medical Oncology (Northwood, London, England)|July 19, 2013
Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastasesFeng Wang, Wei Chen, Hongde Chen, et al.
Iscience|August 2, 2023
GAS5-inhibited hepatocyte pyroptosis contributes to hepatic stellate cell inactivation via microRNA-684 and AHRZhichao Lang, Rongrong Zhang, Xinmiao Li, et al.
Experimental and Molecular Pathology|December 3, 2014
Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese malesWu Zhou, Zhihua Tao, Zhongyong Wang, et al.
Biomolecules & Biomedicine|November 11, 2024
Combined fibrinogen concentration and neutrophil-to-lymphocyte ratio, an integrative model of the inflammatory response and coagulation cascades, for predicting prognosis in patients with upper tract urothelial carcinomaYangqing Zheng, Chen Chen, Chaoyue Lu, et al.
Bosnian Journal of Basic Medical Sciences|January 12, 2022
A HALP score-based prediction model for survival of patients with the upper tract urothelial carcinoma undergoing radical nephroureterectomyXiaomin Gao, Binwei Lin, Qi Lin, et al.
Journal of Medical Virology|October 10, 2023
Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patientsYating Zhan, Qiqi Tao, Zhichao Lang, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|March 8, 2025
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validationYifei Li, Congcong Fan, Feng Jiang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 16, 2015
[Association of polymorphism in the promoter region of PCA3 gene with risk of prosate cancer]Wu Zhou, Zhihua Tao, Zhongyong Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 13, 2023
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11Zhichao Lang, Suhui Yu, Yuhang Hu, et al.
Chemico-Biological Interactions|July 11, 2026
MT2A facilitates the malignant progression of clear cell renal cell carcinoma by activating the TFAP2A/YAP axis via histone lactylationWeiping Huang, Feng Jiang, Weizhi Zhang, et al.
Medical Oncology (Northwood, London, England)|July 19, 2013
Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastasesFeng Wang, Wei Chen, Hongde Chen, et al.
Iscience|August 2, 2023
GAS5-inhibited hepatocyte pyroptosis contributes to hepatic stellate cell inactivation via microRNA-684 and AHRZhichao Lang, Rongrong Zhang, Xinmiao Li, et al.
Experimental and Molecular Pathology|December 3, 2014
Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese malesWu Zhou, Zhihua Tao, Zhongyong Wang, et al.
Biomolecules & Biomedicine|November 11, 2024
Combined fibrinogen concentration and neutrophil-to-lymphocyte ratio, an integrative model of the inflammatory response and coagulation cascades, for predicting prognosis in patients with upper tract urothelial carcinomaYangqing Zheng, Chen Chen, Chaoyue Lu, et al.
Bosnian Journal of Basic Medical Sciences|January 12, 2022
A HALP score-based prediction model for survival of patients with the upper tract urothelial carcinoma undergoing radical nephroureterectomyXiaomin Gao, Binwei Lin, Qi Lin, et al.
Journal of Medical Virology|October 10, 2023
Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patientsYating Zhan, Qiqi Tao, Zhichao Lang, et al.
Pageof 6